MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

News of the day

Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced

5th November 2009 PEMBROKE, Bermuda, November 5 /PRNewswire/ -- Allied World Assurance Company Holdings, Ltd (NYSE: AWH) today reported net income of $200.6 million, or $3.83 per diluted share, for the third quarter of 2009 compared to a net loss of $46.4 million, or $0.95 per diluted share, for the third quarter of 2008. Net income for the nine months ended September 30, 2009 was $445.6 million, or $8.62 per diluted share, compared to net income of $163.8 million, or $3.22 diluted share, for the first nine... more

Shire Continues to Deliver Excellent Growth From Core Products

30th October 2009 DUBLIN, October 30 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to September 30, 2009. more

Torchmark Corporation Reports Third Quarter 2009 Results

28th October 2009 MCKINNEY, Texas, October 28 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended September 30, 2009, net income was US$1.22 per share compared with US$.72 per share for the year-ago quarter. Net operating income for the quarter was US$1.48 per share, a 2% per share decrease compared with US$1.51 per share for the year-ago quarter. Reconciliations between net income and net operating income are shown in the Financial Summary below. more
Conference Call Announcements RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
 

Category

To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Browse by category

More recent news

Torchmark Corporation Announces Third Quarter 2009 Earnings Release and Conference Call
27th October 2009 MCKINNEY, Texas, October 27 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) will release Third Quarter 2009 earnings after the market closes on Wednesday, October 28, 2009. In conjunction with...

PRA International to Host Audio Conference:
26th October 2009 RALEIGH, North Carolina, October 26 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that its Vice President of Clinical Affairs for Early Development...

Torchmark Corporation Announces Third Quarter 2009 Earnings Release and Conference Call
26th October 2009 MCKINNEY, Texas, October 26 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) will release Third Quarter 2009 earnings after the market closes on Wednesday, October 28, 2009. In conjunction with...

Essilor - 2009 Third Quarter Report
22nd October 2009 CHARENTON-LE-PONT, France, October 22 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced its consolidated revenue for the nine months ended September 30,...

Resverlogix Notice of Conference Call & Webcast to Discuss Clinical Trial Data
25th September 2009 CALGARY, Canada, September 25 /PRNewswire/ -- Resverlogix Corp. (TSX:RVX) announced today that it will host a live teleconference and webcast on Tuesday, September 29, 2009 at 1:00 pm Eastern/11:00...

Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer
22nd September 2009 THOUSAND OAKS, California, September 22 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced detailed results from the Phase 3 '181' trial evaluating Vectibix(R) (panitumumab) in combination with...

Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
21st September 2009 THOUSAND OAKS, California, September 21 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus...

Amgen to Present Pivotal Data From Four Phase 3 Studies at the ECCO 15 - ESMO 34 Congress
16th September 2009 THOUSAND OAKS, California, September 16 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced it will present detailed data from four Phase 3 studies as well as other data at the ECCO 15 - ESMO 34...

Algeta Signs $800 Million (EUR560m) Global Agreement With Bayer for Development and Commercialization of Alpharadin for Bone Metastases
3rd September 2009 OSLO, September 3 /PRNewswire/ --

A Wound that Does Not Heal: Frost & Sullivan Reveals the Impact of Chronic Ulcers on the European Healthcare System
25th August 2009 LONDON, August 25 /PRNewswire/ -- Chronic wounds cause immense suffering, healthcare expenditure, and disability for millions of patients - and make the wound care market a billion dollar market....

Amsterdam Molecular Therapeutics Reports Half Year Results 2009
13th August 2009 AMSTERDAM, August 13 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the first half year of 2009.

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
5th August 2009 LONDON, August 5 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to June 30, 2009. Q2 2009 Financial...

Brand New Conference on Developing 21st Century Military Medical Capabilities to be Held in Abu Dhabi
3rd August 2009 ABU DHABI, UAE, August 3 /PRNewswire/ -- The region's first and only summit on military medicine, Defence Healthcare 2009 will be held from 22nd - 25th November 2009 at the Hilton Hotel in Abu...

Radiology Informatics: Frost & Sullivan Examines the Next Big Wave in Medicine
28th July 2009 LONDON, July 28 /PRNewswire/ -- In order to increase productivity, healthcare providers have started to integrate many IT-based ancillary systems such as EMR, HIS and PACS. So far, this has purely...

Essilor : First Half 2009 Revenue
17th July 2009 CHARENTON-LE-PONT, France, July 17 /PRNewswire/ --

Allied World Schedules Second Quarter 2009 Earnings Announcement and Conference Call
8th July 2009 PEMBROKE, Bermuda, July 8 /PRNewswire/ -- Allied World Assurance Company Holdings, Ltd (NYSE: AWH) today announced that it will release its financial results for the second quarter ended June 30,...

Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment
2nd July 2009 NEW BRUNSWICK, New Jersey and DUBLIN, July 2 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) and Elan Corporation plc (NYSE: ELN) today announced a definitive agreement whereby Johnson &...

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us